Galera Therapeutics, Inc.
GRTX
$0.02
$0.00-6.62%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.99M | -13.18M | -16.17M | -18.96M | -19.61M |
| Total Depreciation and Amortization | 0.00 | 5.00K | 11.00K | 20.00K | 235.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.81M | 7.26M | 7.89M | 8.92M | 7.03M |
| Change in Net Operating Assets | -1.62M | -2.41M | -1.32M | -2.13M | -7.37M |
| Cash from Operations | -6.79M | -8.33M | -9.59M | -12.15M | -19.72M |
| Capital Expenditure | -- | -- | -- | -- | -9.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 4.00K | 4.00K | 4.00K | 4.00K |
| Cash Acquisitions | -50.00K | -50.00K | -50.00K | -50.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 3.98M |
| Cash from Investing | -50.00K | -46.00K | -46.00K | -46.00K | 3.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.86M | 2.86M | 2.86M | 2.22M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -2.64M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 2.40M |
| Cash from Financing | 2.86M | 2.86M | 2.86M | 2.22M | -232.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.98M | -5.52M | -6.78M | -9.97M | -15.97M |